Condition: Schizophrenia · Sponsor: Bristol-Myers Squibb
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to evaluate the efficacy and safety of KarXT for treatment of Schizophrenia in adolescents.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Advanced Research Center Inc. | Anaheim, California, United States | Recruiting |
| Inland Psychiatric Medical Group. | Chino, California, United States | Recruiting |
| Local Institution - 0024 | Culver City, California, United States | Not Yet Recruiting |
| Local Institution - 0083 | Redlands, California, United States | Not Yet Recruiting |
| Local Institution - 0089 | San Francisco, California, United States | Not Yet Recruiting |
| Local Institution - 0119 | Hollywood, Florida, United States | Not Yet Recruiting |
| Apg Research, Llc | Orlando, Florida, United States | Recruiting |
| Atlanta Center for Medical Research | Atlanta, Georgia, United States | Recruiting |
| Salveo Integrative Health - Lawrenceville | Lawrenceville, Georgia, United States | Recruiting |
| Denali Health Atlanta, LLC | Stone Mountain, Georgia, United States | Recruiting |
| EmVenio Research Center - Prime Healthcare | Chicago, Illinois, United States | Recruiting |
| Local Institution - 0076 | Boston, Massachusetts, United States | Not Yet Recruiting |
+ 27 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.